AR HOLMBERG, M MARQUEZ… - ANTICANCER …, 2018 - academia.edu
Background/Aim: Prostate-specific membrane antigen (PSMA) is emerging as a target for treatment of castration-resistant prostate cancer (CRPC) while its upregulated in the majority …
AR HOLMBERG, M MARQUEZ… - ANTICANCER …, 2018 - researchgate.net
Background/Aim: Prostate-specific membrane antigen (PSMA) is emerging as a target for treatment of castration-resistant prostate cancer (CRPC) while its upregulated in the majority …
AR HOLMBERG, M MARQUEZ… - ANTICANCER …, 2018 - ar.iiarjournals.org
Background/Aim: Prostate-specific membrane antigen (PSMA) is emerging as a target for treatment of castration-resistant prostate cancer (CRPC) while its upregulated in the majority …
AR Holmberg, M Marquez… - Anticancer …, 2018 - pubmed.ncbi.nlm.nih.gov
Background/aim Prostate-specific membrane antigen (PSMA) is emerging as a target for treatment of castration-resistant prostate cancer (CRPC) while its up-regulated in the …
AR Holmberg, M Marquez, L Lennartsson… - Anticancer …, 2018 - europepmc.org
Materials and methods The PSMA binding pharmacophore Glu-Urea-Lysine (GUL) and lysine were conjugated to oxidized dextran with reductive amination and subsequently …
AR HOLMBERG, M MARQUEZ… - ANTICANCER …, 2018 - academia.edu
Background/Aim: Prostate-specific membrane antigen (PSMA) is emerging as a target for treatment of castration-resistant prostate cancer (CRPC) while its upregulated in the majority …